Open AccessImmunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE
Author(s) -
Emilie Stavnsbjerg Larsen,
Anna Christine Nilsson,
Sören Möller,
Anne Voss,
Işık Somuncu Johansen
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/b8a6zb
Subject(s) - medicine , adverse effect , hydroxychloroquine , regimen , immunogenicity , vaccination , prednisolone , cohort , antibody , prospective cohort study , immunology , gastroenterology , disease , covid-19 , infectious disease (medical specialty)